Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid…

Overview of attention for article published in Investigational New Drugs, February 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Readers on

mendeley: 13 Mendeley

Summary X Facebook

So far, Altmetric has seen 1 X post from an account with 2,069 followers.

Phase 2 study finds amrubicin as effective as doxorubicin for myxoid #liposarcoma w/o hurting the heart. #scmsm https://t.co/kxBkb7ywHH

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.